Skip to main content
. 2019 Mar 14;20(6):1285. doi: 10.3390/ijms20061285
Cis Cisplatin
CLL Chronic lymphocytic leukemia
C max Peak plasma concentration
IC30 Thirty percent of maximal inhibitory concentration
IC50 Half maximal inhibitory concentration
IP Immunoprecipitation
MI-BC Muscle invasive bladder cancer
NAC Neoadjuvant chemotherapy
Veh Vehicle